心包积液的评估

Adler Y, Charron P, Imazio M, et al. 2015 ESC guidelines on the diagnosis and management of pericardial diseases. Eur Heart J. 2015;36:2921-64.全文  摘要

Klein AL, Abbara S, Agler DA, et al. American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with pericardial disease: endorsed by the Society for Cardiovascular Magnetic Resonance and Society of Cardiovascular Computed Tomography. J Am Soc Echocardiogr. 2013 Sep;26(9):965-1012.e15.全文  摘要

Isselbacher EM, Preventza O, Black JH 3rd, et al. 2022 ACC/AHA guideline for the diagnosis and management of aortic disease: a report of the American Heart Association/American College of Cardiology Joint Committee on clinical practice guidelines. Circulation. 2022 Nov 2 [Epub ahead of print].全文  摘要

1. Savage DD, Garrison RJ, Brand F, et al. Prevalence and correlates of posterior extra echocardiographic spaces in a free-living population based sample (the Framingham study). Am J Cardio. 1983;51:1207-12. 摘要

2. Imazio M, Mayosi BM, Brucato A, et al. Triage and management of pericardial effusion. J Cardiovasc Med (Hagerstown). 2010 Dec;11(12):928-35. 摘要

3. Arntfield RT, Millington SJ. Point of care cardiac ultrasound applications in the emergency department and intensive care unit - a review. Curr Cardiol Rev. 2012 May;8(2):98-108.全文  摘要

4. Hoit BD. Pericardial effusion and cardiac tamponade in the new millennium. Curr Cardiol Rep. 2017 Jul;19(7):57. 摘要

5. Adler Y, Charron P, Imazio M, et al. 2015 ESC guidelines on the diagnosis and management of pericardial diseases. Eur Heart J. 2015;36:2921-64.全文  摘要

6. Klein AL, Abbara S, Agler DA, et al. American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with pericardial disease: endorsed by the Society for Cardiovascular Magnetic Resonance and Society of Cardiovascular Computed Tomography. J Am Soc Echocardiogr. 2013 Sep;26(9):965-1012.e15.全文  摘要

7. Strobbe A, Adriaenssens T, Bennett J, et al. Etiology and long-term outcome of patients undergoing pericardiocentesis. J Am Heart Assoc. 2017 Dec 23;6(12):e007598.全文  摘要

8. Agarwal V, El Hayek G, Chavez P, et al. A structured, parsimonious approach to establish the cause of moderate-to-large pericardial effusion. Am J Cardiol. 2014 Aug 1;114(3):479-82. 摘要

9. Sánchez-Enrique C, Nuñez-Gil IJ, Viana-Tejedor A, et al. Cause and long-term outcome of cardiac tamponade. Am J Cardiol. 2016 Feb 15;117(4):664-9. 摘要

10. Ntsekhe M, Mayosi BM. Tuberculous pericarditis with and without HIV. Heart Fail Rev. 2013 May;18(3):367-73.全文  摘要

11. Burazor I, Imazio M, Markel G, et al. Malignant pericardial effusion. Cardiology. 2013;124(4):224-32. 摘要

12. Imazio M, Colopi M, De Ferrari GM. Pericardial diseases in patients with cancer: contemporary prevalence, management and outcomes. Heart. 2020 Apr;106(8):569-74. 摘要

13. Chang HM, Okwuosa TM, Scarabelli T, et al. Cardiovascular complications of cancer therapy: best practices in diagnosis, prevention, and management: Part 2. J Am Coll Cardiol. 2017 Nov 14;70(20):2552-65.全文  摘要

14. Saade A, Mansuet-Lupo A, Arrondeau J, et al. Pericardial effusion under nivolumab: case-reports and review of the literature. J Immunother Cancer. 2019 Oct 18;7(1):266.全文  摘要

15. Imazio M, Adler Y. Management of pericardial effusion. Eur Heart J. 2013 Apr;34(16):1186-97.全文  摘要

16. Pankuweit S, Stein A, Karatolios K, et al. Viral genomes in the pericardial fluid and in peri- and epicardial biopsies from a German cohort of patients with large to moderate pericardial effusions. Heart Fail Rev. 2013 May;18(3):329-36. 摘要

17. Patel H, Patel C, Soni M, et al. Acute primary pneumococcal purulent pericarditis with cardiac tamponade: a case report and literature review. Medicine (Baltimore). 2015 Oct;94(41):e1709.全文  摘要

18. Sotoudeh Anvari M, Kianinejad R, Boroumand MA, et al. Bacterial pericarditis and antimicrobial resistance at the Tehran Heart Center, Iran. J Infect Dev Ctries. 2015 Jul 30;9(7):780-4.全文  摘要

19. Noubiap JJ, Agbor VN, Ndoadoumgue AL, et al. Epidemiology of pericardial diseases in Africa: a systematic scoping review. Heart. 2019 Feb;105(3):180-8. 摘要

20. Porcel JM, Esquerda A, Bielsa S. Diagnostic performance of adenosine deaminase activity in pleural fluid: a single-center experience with over 2100 consecutive patients. Eur J Intern Med. 2010 Oct;21(5):419-23. 摘要

21. Koh KK, Kim EJ, Cho CH, et al. Adenosine deaminase and carcinoembryonic antigen in pericardial effusion diagnosis, especially in suspected tuberculous pericarditis. Circulation. 1994 Jun;89(6):2728-35.全文  摘要

22. Liu J, Mouhayar E, Tarrand JJ, et al. Fulminant Cryptococcus neoformans infection with fatal pericardial tamponade in a patient with chronic myelomonocytic leukaemia who was treated with ruxolitinib: case report and review of fungal pericarditis. Mycoses. 2018 Apr;61(4):245-55. 摘要

23. Biso S, Lekkham R, Climaco A. Aspergillus pericarditis with tamponade in a renal transplant patient. Case Rep Cardiol. 2017;2017:7134586.全文  摘要

24. Rabinovici R, Szewczyk D, Ovadia P, et al. Candida pericarditis: clinical profile and treatment. Ann Thorac Surg. 1997 Apr;63(4):1200-4.全文  摘要

25. Acquatella H. Echocardiography in Chagas heart disease. Circulation. 2007;115:1124-31.全文  摘要

26. Pepi M, Muratori M, Barbier P, et al. Pericardial effusion after cardiac surgery: incidence, site, size, and haemodynamic consequences. Br Heart J. 1997;72:327-31.全文  摘要

27. Ikäheimo MJ, Huikuri HV, Airaksinen KE, et al. Pericardial effusion after cardiac surgery: incidence, relation to the type of surgery, antithrombotic therapy, and early coronary bypass graft patency. Am Heart J. 1988 Jul;116(1 pt 1):97-102. 摘要

28. Khan NK, Järvelä KM, Loisa EL, et al. Incidence, presentation and risk factors of late postoperative pericardial effusions requiring invasive treatment after cardiac surgery. Interact Cardiovasc Thorac Surg. 2017 Jun 1;24(6):835-40.全文  摘要

29. Jaussaud N, Boignard A, Durand M, et al. Percutaneous drainage of postoperative pericardial effusion in cardiac surgery. J Interv Cardiol. 2012 Feb;25(1):95-101.全文  摘要

30. Gaudino M, Anselmi A, Pavone N, et al. Constrictive pericarditis after cardiac surgery. Ann Thorac Surg. 2013 Feb;95(2):731-6.全文  摘要

31. Natanzon A, Kronzon I. Pericardial and pleural effusions in congestive heart failure-anatomical, pathophysiologic, and clinical considerations. Am J Med Sci. 2009 Sep;338(3):211-6. 摘要

32. Sagristà-Sauleda J, Angel J, Permanyer-Miralda G, et al. Long-term follow-up of idiopathic chronic pericardial effusion. N Engl J Med. 1999 Dec 30;341(27):2054-9.全文  摘要

33. Kataoka H. Pericardial and pleural effusions in decompensated chronic heart failure. Am Heart J. 2000;139:918-23. 摘要

34. Batal O, Dardari Z, Costabile C, et al. Prognostic value of pericardial effusion on serial echocardiograms in pulmonary arterial hypertension. Echocardiography. 2015 Oct;32(10):1471-6. 摘要

35. Isselbacher EM, Preventza O, Black JH 3rd, et al. 2022 ACC/AHA guideline for the diagnosis and management of aortic disease: a report of the American Heart Association/American College of Cardiology Joint Committee on clinical practice guidelines. Circulation. 2022 Nov 2 [Epub ahead of print].全文  摘要

36. Gilon D, Mehta RH, Oh JK, et al. Characteristics and in-hospital outcomes of patients with cardiac tamponade complicating type A acute aortic dissection. Am J Cardiol. 2009 Apr 1;103(7):1029-31. 摘要

37. Di Eusanio M, Trimarchi S, Patel HJ, et al. Clinical presentation, management, and short-term outcome of patients with type A acute dissection complicated by mesenteric malperfusion: observations from the International Registry of Acute Aortic Dissection. J Thorac Cardiovasc Surg. 2013 Feb;145(2):385-90.e1.全文  摘要

38. Erbel R, Aboyans V, Boileau C, et al; ESC Committee for Practice Guidelines. 2014 ESC guidelines on the diagnosis and treatment of aortic diseases: document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC). Eur Heart J. 2014 Nov 1;35(41):2873-926.全文  摘要

39. Imazio M, Brucato A, Rovere ME, et al. Contemporary features, risk factors, and prognosis of the post-pericardiotomy syndrome. Am J Cardiol. 2011 Oct 15;108(8):1183-7. 摘要

40. Albani S, Fabris E, Stolfo D, et al. Prognostic relevance of pericardial effusion in STEMI patients treated by primary percutaneous coronary intervention: a 10-year single-centre experience. Eur Heart J Acute Cardiovasc Care. 2019 Nov 7 [Epub ahead of print].全文  摘要

41. Bière L, Mateus V, Clerfond G, et al. Predictive factors of pericardial effusion after a first acute myocardial infarction and successful reperfusion. Am J Cardiol. 2015 Aug 15;116(4):497-503. 摘要

42. Harris DG, Janson JT, Van Wyk J, et al. Delayed pericardial effusion following stab wounds to the chest. Eur J Cardiothorac Surg. 2003;23:473-6. 摘要

43. Bataille S, Brunet P, Decourt A, et al. Pericarditis in uremic patients: serum albumin and size of pericardial effusion predict drainage necessity. J Nephrol. 2015 Feb;28(1):97-104. 摘要

44. Cuomo JR, Sharma GK, Conger PD, et al. Novel concepts in radiation-induced cardiovascular disease. World J Cardiol. 2016 Sep 26;8(9):504-19.全文  摘要

45. Szpakowski N, Desai MY. Radiation-associated pericardial disease. Curr Cardiol Rep. 2019 Jul 27;21(9):97. 摘要

46. Ning MS, Tang L, Gomez DR, et al. Incidence and predictors of pericardial effusion after chemoradiation therapy for locally advanced non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2017 Sep 1;99(1):70-9. 摘要

47. Mohty D, Damy T, Cosnay P, et al. Cardiac amyloidosis: updates in diagnosis and management. Arch Cardiovasc Dis. 2013 Oct;106(10):528-40.全文  摘要

48. Imazio M. Pericardial involvement in systemic inflammatory diseases. Heart. 2011 Nov;97(22):1882-92. 摘要

49. Chahine J, Ala CK, Gentry JL, et al. Pericardial diseases in patients with hypothyroidism. Heart. 2019 Jul;105(13):1027-33. 摘要

50. Delvigne A, Demoulin A, Smitz J, et al. The ovarian hyperstimulation syndrome in in-vitro fertilization: a Belgian multicentric study. I. Clinical and biological features. Hum Reprod. 1993 Sep;8(9):1353-60. 摘要

51. Le Saché F, Dibie A, Lamer C. Cardiac tamponade after ovarian stimulation. N Engl J Med. 2007 Jan 25;356(4):425-6. 摘要

52. Vasoo S. Drug-induced lupus: an update. Lupus. 2006;15:757-61. 摘要

53. Ristić AD, Imazio M, Adler Y, et al. Triage strategy for urgent management of cardiac tamponade: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2014 Sep 7;35(34):2279-84.全文  摘要

54. LeWinter MM. Clinical practice. Acute pericarditis. N Engl J Med. 2014 Dec 18;371(25):2410-6. 摘要

55. Aringer M, Costenbader K, Daikh D, et al. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019 Sep;78(9):1151-9.全文  摘要

56. Weitzman LB, Tinker WP, Kronzon I, et al. The incidence and natural history of pericardial effusion after cardiac surgery - an echocardiographic study. Circulation. 1984;69:506-11. 摘要

57. Roy CL, Minor MA, Brookhart MA, et al. Does this patient with a pericardial effusion have cardiac tamponade? JAMA. 2007 Apr 25;297(16):1810-8. 摘要

58. Xanthopoulos A, Skoularigis J. Diagnosis of acute pericarditis. E-J Cardiol Pract. 2017;15:15.全文

59. Kligerman S. Imaging of pericardial disease. Radiol Clin North Am. 2019 Jan;57(1):179-99. 摘要

60. Chetrit M, Xu B, Kwon DH, et al. Imaging-guided therapies for pericardial diseases. JACC Cardiovasc Imaging. 2020 Jun;13(6):1422-7. 摘要

61. Sagrista-Sauleda J, Merce J, Permanyer-Miralda G, et al. Clinical clues to the causes of large pericardial effusions. Am J Med. 2000 Aug 1;109(2):95-101. 摘要

62. Permanyer-Miralda G, Sagrista-Sauleda J, Soler-Soler J. Primary acute pericardial disease: a prospective series of 231 consecutive patients. Am J Cardiol. 1985;56:623-30. 摘要

63. Argulian E, Makani H, Herzog E. Pericardial effusion and tamponade. In: Herzog E (ed). Management of pericardial disease. Switzerland: Springer International Publishing; 2014:129-37.

64. Ben-Horin S, Bank I, Shinfeld A, et al. Diagnostic value of the biochemical composition of pericardial effusions in patients undergoing pericardiocentesis. Am J Cardiol. 2007;99:1294-7. 摘要

65. Seferović PM, Ristić AD, Maksimović R, et al. Diagnostic value of pericardial biopsy: improvement with extensive sampling enabled by pericardioscopy. Circulation. 2003;107:978-83.全文  摘要

66. Mayosi BM, Burgess LJ, Doubell AF. Tuberculous pericarditis. Circulation. 2005;112:3608-16.全文  摘要

67. Mayosi BM, Wiysonge CS, Ntsekhe M, et al. Clinical characteristics and initial management of patients with tuberculous pericarditis in the HIV era: the Investigation of the Management of Pericarditis in Africa (IMPI Africa) registry. BMC Infect Dis. 2006;6:2.全文  摘要

68. Dorbala S, Ando Y, Bokhari S, et al. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 1 of 2 - evidence base and standardized methods of imaging. Circ Cardiovasc Imaging. 2021 Jul;14(7):e000029.全文  摘要

69. Garcia-Pavia P, Rapezzi C, Adler Y, et al. Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2021 Apr 21;42(16):1554-68.全文  摘要

70. Gillmore JD, Maurer MS, Falk RH, et al. Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation. 2016 Jun 14;133(24):2404-12.全文  摘要